Redalpine closes $250M RAC VIII fund for European startups

Seed and Series A focus

RAC VIII will invest mainly at seed and Series A, with cheques of between $1m and $15m. Redalpine says it will aim to lead or co-lead rounds, and expects to back between 15 and 20 startups. Focus areas include robotics and AI for drug discovery.

Half of the firm's investment team are scientists, which fits its emphasis on deep technology. The company says startups backed by RAC VII, whose portfolio is nearly 50 per cent UK-based, have since raised more than $1.1bn in total funding.

Why it matters

The close adds fresh early-stage capital for European founders working on science-heavy problems, an area where round sizes and investor expertise often determine whether companies can scale at home.

Sebastian Becker, general partner at Redalpine, framed the fund around that opportunity. "AI is levelling the playing field more than ever. The advantage now lies with whoever understands the underlying science and the hardest problems best, and that has always been Europe's strength," he said.

Becker added that the firm is seeing a new generation of highly ambitious founders determined to build and scale world-leading technology companies in Europe and establish the continent as a global technology power.